Bharat Maritime Insurance Pool: How will it complement international legacy players?

BMIP, launched by government, will function complimentary to international insurers as its global recognition requires time ...
Healio

FDA accepts cemdisiran for review to treat generalized myasthenia gravis

Cemdisiran, a potential new drug for the treatment of generalized myasthenia gravis, has been accepted for priority review by ...
Fierce Pharma

FDA approves Vera’s dual-target Trutakna, setting up IgAN market battle with Novartis, Otsuka

When Vera Therapeutics in-licensed atacicept from Merck KGaA about six years ago, patients with IgA nephropathy (IgAN) had no ...
Nature

Mechanisms of Disease: the complement system in renal injury—new ways of looking at an old foe

The fact that the complement system is activated during immune-complex glomerular disease has been known for nearly 50 years. Detection of complement deposition in the glomerulus using immunochemistry ...

AMD: Market Has Completely Misread The AI CPU Supercycle

AMD EPYC is poised for the AI CPU supercycle, powering inference and agentic AI with strong TCO and efficiency—alongside Instinct & Helios. Click for this update.